Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents
2 other identifiers
observational
50
1 country
1
Brief Summary
Little is known about eye drop regime adherence in the paediatric population. In particular, no previous research has investigated this in the paediatric uveitis population, a group who can require doses up to six times daily, and at frequencies that change month to month. The aim of the study is to quantify the range of adherence to eye drop medication, and to investigate some of the reasons for non-compliance in a child specific study. By learning more about compliance, this will help create treatments that are better suited to children. The study will recruit 50 children receiving eye drop treatment. After an interval of 1 week or more the children and their parents will be asked to complete a questionnaire about the frequency of the drops prescribed, and the frequency that they have used over the last interval. It will also ask questions about difficulties encountered administering the drops. Changes in eye drop bottle weight will be measured during the interval and the result compared. The information gathered from the questionnaires will be used to compare reports of adherence between the parent and child, the child's age and the bottle weight. The reasons reported for difficulties with adherence will also be reported. This is a preliminary investigatory study to identify whether an issue with medication non-adherence exists. The findings will be used to tailor further research into this area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2019
CompletedFirst Posted
Study publicly available on registry
November 1, 2019
CompletedStudy Start
First participant enrolled
February 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedAugust 11, 2021
August 1, 2021
1.2 years
October 30, 2019
August 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of reported medication errors (missed doses) among paediatric uveitis population.
to determine what level of compliance with eye drop regimes currently exists in the paediatric uveitis population.
01/07/2020
Secondary Outcomes (3)
What factors effect adherence to eye drop regimes? Including the frequency of eye drops and who administers the eye drops.
01/07/2020
Does the age of the child influence compliance?
01/07/2020
In children that are old enough to report drop use, is reported compliance comparable between child and parent?
01/07/2020
Study Arms (1)
Paediatric Uveitis
Patients with Uveitis below the age of 18 years.
Eligibility Criteria
Paediatric uveitis population who attend Paediatric Ophthalmology Department Uveitis Clinic.
You may qualify if:
- Any child attending the Paediatric Ophthalmology Department Uveitis Clinic who is receiving eye drop treatment.
- Children with a diagnosis of uveitis receiving eye drop treatment between 0-18 years of age at the time of recruitment.
You may not qualify if:
- Children with follow up more than 3 months after the first meeting and consent will subsequently be excluded.
- At present the study does not have sufficient funding for translators. Potential participants that do not speak sufficient English to understand and respond to the questionnaire will be excluded. We hope to obtain additional funding following this preliminary research. A priority of any further work will be to provide translators and achieve a more inclusive approach.
- Children not accompanied by a person with parental responsibility will be excluded if they cannot provide their own consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manchester Royal Eye Hospital
Manchester, M13 9WL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jane Ashworth
Consultant Peadiatric Ophthalmologist
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2019
First Posted
November 1, 2019
Study Start
February 14, 2020
Primary Completion
April 30, 2021
Study Completion
May 30, 2021
Last Updated
August 11, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share